Published in TB and Outbreaks Week, November 5th, 2002
Biosearch will use the funds mainly to boost output of key ingredients, which is essential to meet increased demand to support preclinical and clinical development of its lead drugs.
Biosearch will concentrate on the following activities: strain improvement, fermentation development, and downstream optimization related to its...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.